Articles from Genovyn Inc.

Genovyn Appoints Industry Veterans Sammy Bell as Chief Scientific Officer and Jim Edinger as Chief Development Officer to Accelerate AI-Enabled Therapeutic Discovery and Development
Leadership appointments fortify Genovyn’s scientific, translational, and development capabilities across its AI-driven platform
By Genovyn Inc. · Via GlobeNewswire · June 4, 2026
Articles from Genovyn Inc. | WAOW